All accepted abstracts will be published in our official Conference Proceedings, ensuring a permanent record of your contribution and wide visibility within our community.
We are proud to partner with Journal of Respiratory Biology and Translational Medicine. We invite speakers to submit their full papers for a special publication opportunity in the journal.
Novel therapeutic targets, small molecules, biologics, drug delivery systems, and innovations in preclinical R&D. Case studies in accelerating the drug pipeline.
Decentralized clinical trials (DCTs), patient recruitment strategies, digital endpoints, adaptive trial design, and navigating global regulatory pathways (FDA, EMA).
Pharmacogenomics (PGx), companion diagnostics, biomarker discovery, and development of tailored therapeutics based on genetic markers and patient data.
Breakthroughs in cell and gene therapy, CRISPR/Cas9 applications, mRNA vaccines and therapeutics, monoclonal antibodies, and advanced biologics.
AI in medical diagnostics, ML for medical imaging analysis, predictive modeling for patient outcomes, generative AI for drug discovery, and computational biology.
Wearable technology, remote patient monitoring, digital therapeutics (DTx), Software as a Medical Device (SaMD), and the role of IoT in patient care.
Data interoperability (FHIR, OMOP), data governance in healthcare, analytics for Real-World Evidence (RWE), patient data privacy, and FAIR data principles.
Health Economics and Outcomes Research (HEOR), patient-reported outcomes (PROs), post-market surveillance, and strategies for medical affairs in a digital-first world.
Ethical considerations in clinical trials, mitigating bias in diagnostic AI, patient consent in the digital age, and ensuring equitable access to novel therapies.
Specific breakthroughs and case studies in Oncology, Neurology, Cardiology, Immunology, or other major therapeutic areas. Please specify in your submission.
